SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 8, 2023, reporting events that occurred on November 2, 2023. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the adoption of Amendment No. 3 to the Company's Amended and Restated Bylaws, effective November 2, 2023. This amendment modifies Article II, Section 2.9 regarding voting requirements at stockholder meetings:
- Election of Directors: Requires a plurality of the votes cast.
- All Other Matters: Requires the affirmative vote of the holders of a majority in voting power of the votes cast (excluding abstentions and broker non-votes).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the bylaw amendment.
Investor Verification Checklist
- Verify the full text of Exhibit 3.1 (Amendment No. 3) to understand the complete legal language of the bylaw changes.
- Confirm the impact of the new "majority voting" standard for non-director matters on future shareholder proposals.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).